Italy's Confindustria prepares strategy drive - medtech industry figure in new team
This article was originally published in Clinica
Italy’s pan-industrial confederation, Confindustria, which includes the medical technology association Assobiomedica, has unveiled a new policy strategy team tasked with drawing up a blueprint for “real industrial development” in Italy. The team is the brainchild of Confindustria’s newly-appointed president-designate, Giorgio Squinzi.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.